Le Lézard
Classified in: Health
Subject: SVY

Global Neurovascular Intervention Market (2018-2024) Covering: Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever Systems


DUBLIN, Dec. 7, 2018 /PRNewswire/ --

The "Global Neurovascular Intervention Market - (By Type-Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System; By Region- North America, Europe & Asia Pacific) Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Growth of global neurovascular intervention market is propelled by rising prevalence of cerebrovascular diseases, higher incidences of neurological disorders, favourable reimbursement policies and expanding healthcare infrastructure.

However, the market faces several challenges such as high treatment cost, multiple products recalls, the dearth of skilled neurosurgeons and social stigma.

The report provides in-depth analysis of the current scenario, detailed market outlook of the global neurovascular intervention market with coverage on major market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System. Future forecasts of neurovascular intervention overall and across various sub-segments till 2024 are provided in the report.

Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Key Vendors

These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section.

In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global neurovascular intervention market.

Topics Covered

1. Executive Summary

2. Research Methodology

3. Neurovascular Market
3.1 Introduction
3.1.1 Background
3.1.2 Neurovascular Devices
3.2 Market Analysis
3.2.1 Market Sizing (Actual & Forecasted)
3.2.2 Market Share by Region
3.2.3 Market Share by Therapeutic Application
3.2.4 Market Share by Technique

4. Global Neurovascular Market Segmentation
4.1 Cerebral Thrombectomy Devices
4.2 Flow Diverter for Aneurysm
4.3 Carotid Artery Stenting (CAS) System
4.4 Stent Retriever Market

5. Regional Analysis
5.1 North America (The US)
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Segment
5.1.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
5.1.4 Flow Diverter Devices Market Sizing (Actual & Forecasted)
5.1.5 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
5.2 Europe
5.2.1 Market Sizing (Actual & Forecasted)
5.2.2 Market Share by Segment
5.2.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
5.2.4 Flow Diverter Devices Market Sizing (Actual & Forecasted)
5.3 Asia Pacific
5.3.1 Market Sizing (Actual & Forecasted)
5.3.2 Market Share by Segment
5.3.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)

6. Global Neurovascular Market Dynamics
6.1 Industry Trends & Developments
6.1.1 Mergers & Acquisitions
6.1.2 Technological Advancement
6.1.3 Advent of ARTS (Aspiration-Retriever Technique for Stroke)
6.2 Growth Drivers
6.2.1 Rising Prevalence of Cerebrovascular disease
6.2.2 Higher Incidences of Neurological Disorders
6.2.3 Favorable Reimbursement Policies
6.2.4 Expanding Healthcare Infrastructure
6.3 Challenges
6.3.1 High Cost of Treatment
6.3.2 Multiple Product Recalls
6.3.3 Dearth of Skilled Neurosurgeons
6.3.4 Social Stigma

7. Competitive Landscape
7.1 Global
7.2 Regional

8. Company Profiles
8.1 Johnson & Johnson DePuy Synthes
8.2 Stryker Corporation
8.3 Medtronic PLC
8.4 Penumbra Inc.
8.5 Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/research/s25j54/global?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: